These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 6388170)

  • 1. [The antifungal agent naftifin. Placebo-controlled therapeutic comparison in tinea pedis].
    Klaschka F; Gartmann H; Weidinger G
    Z Hautkr; 1984 Sep; 59(18):1218-26. PubMed ID: 6388170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Multicenter double-blind contralateral comparison of naftifin and clotrimazole cream in patients with dermatophytosis and candidiasis].
    Zaun H; Luszpinski P
    Z Hautkr; 1984 Sep; 59(18):1209-17. PubMed ID: 6388169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of naftifine HCl Gel 2% in the treatment of interdigital and moccasin type tinea pedis: pooled results from two multicenter, randomized, double-blind, vehicle-controlled trials.
    Stein Gold LF; Parish LC; Vlahovic T; Plaum S; Kircik L; Fleischer AB; Verma A; Olayinka B; Hardas B
    J Drugs Dermatol; 2013 Aug; 12(8):911-8. PubMed ID: 23986165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Naftifin in foot mycoses. Double-blind therapeutic comparison with clotrimazole].
    Haas PJ; Tronnier H; Weidinger G
    Mykosen; 1985 Jan; 28(1):33-40. PubMed ID: 3883160
    [No Abstract]   [Full Text] [Related]  

  • 5. Naftifine Hydrochloride Gel 2%: An Effective Topical Treatment for Moccasin-Type Tinea Pedis.
    Stein Gold LF; Vlahovic T; Verma A; Olayinka B; Fleischer AB
    J Drugs Dermatol; 2015 Oct; 14(10):1138-44. PubMed ID: 26461826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naftifine cream 1% versus clotrimazole cream 1% in the treatment of tinea pedis. Naftifine Podiatric Study Group.
    J Am Podiatr Med Assoc; 1990 Jun; 80(6):314-8. PubMed ID: 2189989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antimycotic effect of naftifin in tinea pedis. Comparative double-blind study with bifonazole].
    Bojanovsky A; Haas P
    Fortschr Med; 1985 Jul; 103(25):677-9. PubMed ID: 3897005
    [No Abstract]   [Full Text] [Related]  

  • 8. Naftifine gel in the treatment of tinea pedis: two double-blind, multicenter studies. Naftifine Gel Study Group.
    Cutis; 1991 Jul; 48(1):85-8. PubMed ID: 1868748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind, vehicle-controlled efficacy and safety study of naftifine 2% cream in the treatment of tinea pedis.
    Parish LC; Parish JL; Routh HB; Fleischer AB; Avakian EV; Plaum S; Hardas B
    J Drugs Dermatol; 2011 Nov; 10(11):1282-8. PubMed ID: 22052309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Naftifine HCl 2% Gel and Cream in Treating Moccasin Tinea Pedis.
    Vlahovic TC
    J Drugs Dermatol; 2016 Feb; 15(2 Suppl):s56-9. PubMed ID: 26885800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the efficacy of a new antimycotic molecule for topical use: naftifine].
    Albanese G; Giorgetti P; Santagostino L; Di Cintio R; Colombo MD
    G Ital Dermatol Venereol; 1989 May; 124(5):XXXIII-XXXVII. PubMed ID: 2620916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Open-Label, Multi-Center, Multiple-Application Pharmacokinetic Study of Naftifine HCl Gel 2% in Pediatric Subjects With Tinea Pedis.
    Verma A; Olayinka B; Fleischer AB
    J Drugs Dermatol; 2015 Jul; 14(7):686-91. PubMed ID: 26151784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled study.
    Ortonne JP; Korting HC; Viguié-Vallanet C; Larnier C; Savaluny E
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1307-13. PubMed ID: 17062050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allylamines: topical and oral treatment of dermatomycoses with a new class of antifungal agents.
    Ganzinger U; Stutz A; Petranyi G; Stephen A
    Acta Derm Venereol Suppl (Stockh); 1986; 121():155-60. PubMed ID: 3459341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naftifine cream in the treatment of cutaneous candidiasis.
    Zaias N; Astorga E; Cordero CN; Day RM; de Espinoza ZD; DeGryse R; Rojas RF; Sefton J
    Cutis; 1988 Sep; 42(3):238-40. PubMed ID: 3048914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing topical antifungal therapy for superficial cutaneous fungal infections: focus on topical naftifine for cutaneous dermatophytosis.
    Del Rosso JQ; Kircik LH
    J Drugs Dermatol; 2013 Nov; 12(11 Suppl):s165-71. PubMed ID: 24196340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naftifine solution (1%) in the treatment of pityriasis versicolor in Zambia.
    Hira SK; Abraham MS; Mwinga A; Kamanga J; Schmidt C
    Mykosen; 1986 Aug; 29(8):378-81. PubMed ID: 3531847
    [No Abstract]   [Full Text] [Related]  

  • 18. Once daily treatment with terbinafine 1% cream (Lamisil) for one week is effective in the treatment of tinea corporis and cruris. A placebo-controlled study.
    Budimulja U; Bramono K; Urip KS; Basuki S; Widodo G; Rapatz G; Paul C
    Mycoses; 2001; 44(7-8):300-6. PubMed ID: 11714065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy of naftifine, oxiconazole, and terbinafine in short-term treatment of tinea pedis.
    Ablon G; Rosen T; Spedale J
    Int J Dermatol; 1996 Aug; 35(8):591-3. PubMed ID: 8854165
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of naftifine hydrochloride 2% cream and 39% urea cream in the treatment of tinea pedis complicated by hyperkeratosis.
    Kircik LH; Onumah N
    J Drugs Dermatol; 2014 Feb; 13(2):162-5. PubMed ID: 24509966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.